Discover the most talked about and latest scientific content & concepts.

M Syed, C Skonberg and SH Hansen
Diclofenac is a widely prescribed NSAID, which by itself and its reactive metabolites (Phase-I and Phase-II) may be involved in serious idiosyncratic hepatotoxicity. Mitochondrial injury is the one of the mechanism of drug induced liver injury (DILI). In the present work, an investigation of the inhibitory effects of diclofenac (Dic) and its phase I [4-hydroxy diclofenac (4'-OH-Dic) and 5-hydroxy diclofenac (5-OH-dic)] and Phase-II [diclofenac acyl glucuronide (DicGluA) and diclofenac glutathione thioester (DicSG)] metabolites, on ATP synthesis in rat liver mitochondria were carried out. A mechanism based inhibition of ATP synthesis is excerted by diclofenac and its metabolites. Phase-I metabolite (4'-OH-Dic) and Phase-II metabolites (DicGluA and DicSG) showed potent inhibition (2-5 fold) of ATP synthesis, where as 5-OH-Dic, one of the Phase-I metabolite, was a less potent inhibitor as compared to Dic. The calculated kinetic constants of mechanism based inhibition of ATP synthesis by Dic showed maximal rate of inactivation (Kinact) of 2.64±0.15min(-1) and half maximal rate of inactivation (KI) of 7.69±2.48μM with Kinact/KI ratio of 0.343min(-1)μM(-1). Co-incubation of mitochondria with Dic and reduced GSH exhibited a protective effect on Dic mediated inhibition of ATP synthesis. Our data from this study strongly indicate that Dic as well as its metabolites could be involved in the hepato-toxic action through inhibition of ATP synthesis.
Facebook likes*
News coverage*
SC clicks
Reactive oxygen species, ATP synthase, Photosynthesis, Mitochondrion, Metabolism, Cellular respiration, Oxidative phosphorylation, Adenosine triphosphate
MeSH headings
comments powered by Disqus

* Data courtesy of